Cite

HARVARD Citation

    Gooden, C. et al. (2018). CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma. Cytometry. 94 (1), pp. 129-135. [Online]. 
  
Back to record